Age-related macular degeneration (AMD), the leading cause of legal blindness
in people 65 years or older in the United States,1 is
a degenerative disorder of the retinal pigment epithelium (RPE) and neurosensory
retina. The macula is the portion of the central retina with the greatest
concentration of photoreceptors and provides high-resolution visual acuity.
The early stages of AMD are characterized clinically by the development of
soft drusen associated with pigmentary abnormalities of the RPE and retina
(Figure 1A). Drusen, accumulations
of amorphous, acellular debris within the basement membrane of the RPE, are
seen ophthalmoscopically as yellow spots within the macula.2 While
small drusen are commonly present in the macula as a consequence of aging,
the presence of large and numerous drusen is associated with AMD.3 Late-stage AMD is characterized by the development
of well-defined areas of RPE loss (geographic atrophy) (Figure 1B), choroidal neovascularization (CNV) (Figure 1C), pigment epithelial detachment, and fibrous scarring
of the macula (disciform scarring).2,4 The
presence of soft drusen, pigmentary abnormalities, and geographic atrophy
is commonly termed dry (nonneovascular) AMD. The development of CNV, pigment
epithelial detachment, or disciform scarring is an exudative process and commonly
termed wet (neovascular) AMD. The wet form of AMD comprises approximately
15% of the cases,5 but because of its severity,
accounts for the majority of severe visual loss due to AMD.6
Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more
Subscribe for full-text access to content from 1998 forward and a host of useful features
Activate your current subscription (AMA members and current subscribers)
Purchase Online Access to this article for 24 hours
Country-Specific Mortality and Growth Failure in Infancy and Yound Children and
Association With Material Stature
Use interactive graphics and maps to view and sort country-specific infant and early
dhildhood mortality and growth failure data and their association with maternal
Thank you for submitting a comment on this article. It will be reviewed by JAMA editors. You will be notified when your comment has been published. Comments should not exceed 500 words of text and 10 references.
Do not submit personal medical questions or information that could identify a specific patient, questions about a particular case, or general inquiries to an author. Only content that has not been published, posted, or submitted elsewhere should be submitted. By submitting this Comment, you and any coauthors transfer copyright to the journal if your Comment is posted.
* = Required Field
Disclosure of Any Conflicts of Interest*
Indicate all relevant conflicts of interest of each author below, including all relevant financial interests, activities, and relationships within the past 3 years including, but not limited to, employment, affiliation, grants or funding, consultancies, honoraria or payment, speakers’ bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued. If all authors have none, check "No potential conflicts or relevant financial interests" in the box below. Please also indicate any funding received in support of this work. The information will be posted with your response.
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Web of Science® Times Cited: 31
Customize your page view by dragging & repositioning the boxes below.
More Listings atJAMACareerCenter.com >
and access these and other features:
Enter your username and email address. We'll send you a link to reset your password.
Enter your username and email address. We'll send instructions on how to reset your password to the email address we have on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.